Investigations

SentintelOne Subject to Investigation: Johnson Fistel Seeks Remedies for Investors After the Stock Drop (S) Johnson Fistel, LLP, a shareholder rights law firm, is investigating SentinelOne, Inc. (NYSE: S) to determine whether investors who suffered significant losses on their investment may be able to recover their losses under federal securities laws. On June 1, 2023, SentinelOne announced a restatement to its annual recurring revenue (ARR) due to a change in methodology and the correction of historical inaccuracies. Additionally, the Company cut its FY 2024 revenue guidance to a range of $590M to $600M from $631M to $640M. Following this news, SentinelOne stock price dropped as much as 36% in pre-market trading on June 2, 2023. Our firm works on a contingency fee basis which means there will be no cost to you. Contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. If you have relevant nonpublic information about the company, consider

DZS Shareholder Alert: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Recent News (DZSI) Shareholder rights law firm Johnson Fistel, LLP is investigating whether DZS Inc. (NASDAQ: DZSI), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased DZS common stock? If you purchased DZS common stock and suffered significant losses on your investment, join our investigation now: For more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On June 1, 2023, DZS announced that it will restate its financial statements for the first quarter of 2023, which ended March 31, 2023. The restatement relates to the timing of revenue recognition concerning

Comerica Incorporated Subject to Investigation: Johnson Fistel Seeks Remedies for Investors After the Stock Drop (CMA) Johnson Fistel, LLP, a shareholder rights law firm, is investigating Comerica Incorporated (“Comerica” or “the Company”) (NYSE: CMA) to determine whether investors who suffered significant losses on their investment may be able to recover their losses under federal securities laws. Join Our Investigation Here: https://www.cognitoforms.com/johnsonfistel/comericaincorporated On May 30, 2023, American Banker issued an article titled “Comerica in ‘serious violation’ of Treasury’s Direct Express program”. The article states “Comerica Bank officials privately acknowledged significant compliance failures in their operation of a Treasury Department program that provides federal benefits on prepaid cards to millions of unbanked Americans.” The article further states that Comerica executive said the bank faced “serious contract violation” for allowing fraud disputes and data on Direct Express cardholders to be handled out of a vendor’s office in Lahore, Pakistan, the documents show. Personally

Integra LifeScience Subject to Investigation: Johnson Fistel Seeks Remedies for Investors After the Stock Drop (IART) Johnson Fistel, LLP, a shareholder rights law firm, is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) to determine whether investors who suffered significant losses on their investment may be able to recover their losses under federal securities laws. Integra made an announcement on May 23, 2023, stating that it had conducted an internal investigation, leading to a global recall of all products produced at its Boston, Massachusetts facility. The affected products were distributed between March 1, 2018, and May 22, 2023. The company ceased manufacturing operations at the facility. The reason behind these actions was the company “identified deviations with endotoxin testing that may have resulted in the release of products with higher levels of endotoxins than permitted by the product specifications”. Integra disclosed that it anticipates a material impairment charge related to the

Bowlero Corp. Subject to Investigation: Johnson Fistel Seeks Remedies for Investors After the Stock Drop – BOWL Johnson Fistel, LLP, a shareholder rights law firm, is investigating Bowlero Corp. (“Bowlero” or “the Company”) (NYSE: BOWL) to determine whether investors who suffered significant losses on their investment may be able to recover their losses under federal securities laws. On May 17, 2023, Bowlero Corp. released its Q3 2023 financial results after the market closed. The results also disclosed information about the effectiveness of Bowlero’s disclosure controls and procedures. The company identified a significant weakness in its financial reporting processes, particularly in areas such as acquisition accounting, fixed asset accounting, and specific financial reporting disclosures. Bowlero also acknowledged the absence of well-designed and maintained controls over system access, which affected the segregation of duties for individuals responsible for the general ledger. Our firm works on a contingency fee basis which means there

Hyatt Long-Term Shareholder Alert: Contact Johnson Fistel if You Are a Long-Term Shareholder for More Information (H). Johnson Fistel, LLP is investigating potential claims on behalf of Hyatt Hotels Corporation (“Hyatt” or “the Company”) (NYSE: H). If you are a current, long-term shareholder of Hyatt you can submit your information below: On May 16, 2023, it was reported that Texas Attorney General Ken Paxton is suing Hyatt Hotels for violating state law by “marketing hotel rooms at prices that were not available to the public,” according to the lawsuit.  If you are interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.  About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action

DouYu International Shareholder News: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Class Action Investigation – DOYU Shareholder rights law firm Johnson Fistel, LLP is investigating whether DouYu International Holdings Limited (“DouYu” or “the Company”) (NASDAQ: DOYU) any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased DouYu common stock? If you purchased DouYu common stock and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On May 9, 2023, DouYu announced that a team sent by Hubei provincial branch of the Cyberspace Administration of China (the “CAC”) will conduct

JinkoSolar Shareholder News: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Class Action Investigation – JKS Shareholder rights law firm Johnson Fistel, LLP is investigating whether JinkoSolar Holding Co., Ltd. (NYSE: JKS) (“JinkoSolar” or the “Company”) any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased JinkoSolar common stock? If you purchased JinkoSolar common stock and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On May 8, 2023, it was reported in the Florida Times that JinkoSolar was raided by federal agents. Federal authorities did not disclose the reason

Icahn Enterprises Shareholder News: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Investigation – IEP Shareholder rights law firm Johnson Fistel, LLP is investigating whether Icahn Enterprises L.P. (NASDAQ: IEP), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Icahn Enterprises common stock? If you purchased Icahn Enterprises common stock and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On May 2, 2023, Hindenburg Research released a report outlining its concerns regarding Icahn Enterprises. The firm alleges that IEP units are inflated by up to 75% stating, “(1)

Investigation Alert Catalent: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT)against certain of its officers and directors. If you have continuously owned Catalent shares before August 30, 2021 you can click submit your information below: Recently a class action lawsuit was filed against the company. The complaint alleges that defendants made false statements and/or concealed that: a) Catalent materially overstated its revenue and earnings by prematurely recognizing revenue in violation of U.S. Generally Accepted Accounting Principles (“GAAP”); b) Catalent had material weaknesses in its internal control over financial reporting related to revenue recognition; c) Catalent falsely represented demand for its products while it knowingly sold more product to its direct customers than could be sold to healthcare providers and end consumers; d) Catalent disregarded regulatory rules at key production

Investigation Alert Alico: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of Alico, Inc. (“Alico” or the “Company”) (NASDAQ: ALCO) against certain of its officers and directors. If you are a current, long-term shareholder of Alico holding shares before February 4, 2021, you may have standing to hold Alico harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. You can submit your information below: Recently a class action lawsuit was filed against the company. The complaint alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) Alico had deficient disclosure controls and procedures and internal control over financial reporting; (2) as a result, the Company had improperly calculated Alico’s

Investigation Alert Fate Therapeutics: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of Fate Therapeutics, Inc. (“Fate” or the “Company”) (NASDAQ: FATE). If you are a current, long-term shareholder of Fate Therapeutics holding shares before April 2, 2020, you can submit your information below: Recently a class action lawsuit was filed against the company. The complaint alleges, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors; (ii) accordingly, certain the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources; (iii) as a result, Fate had overstated the impact of

Investigation Alert Caribou Biosciences: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm Regarding Investigation Caribou Biosciences, Inc. (NASDAQ: CRBU) Johnson Fistel, LLP is investigating potential claims on behalf of Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU) against certain of its officers and directors. If you are a current, long-term shareholder of Caribou Biosciences, Inc. you may have standing to hold Caribou Biosciences, Inc. harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. Recently a class action lawsuit was filed against the company. The complaint alleges that defendants made false statements and/or concealed that: (i) the treatment effect of the Company’s product candidate, CB-010, was not as durable as defendants had led investors to believe; (ii) accordingly, CB-010’s clinical and commercial prospects